These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10867250)

  • 1. Characterization of a diltiazem-lambda carrageenan complex.
    Bonferoni MC; Rossi S; Ferrari F; Bettinetti GP; Caramella C
    Int J Pharm; 2000 May; 200(2):207-16. PubMed ID: 10867250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factorial analysis of the influence of dissolution medium on drug release from carrageenan-diltiazem complexes.
    Bonferoni MC; Rossi S; Ferrari F; Stavik E; Pena-Romero A; Caramella C
    AAPS PharmSciTech; 2000 Jun; 1(2):E15. PubMed ID: 14727848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of oral controlled-release tablet formulations based on diltiazem-carrageenan complex.
    Bonferoni MC; Rossi S; Ferrari F; Caramella C
    Pharm Dev Technol; 2004; 9(2):155-62. PubMed ID: 15202574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug release kinetics and front movement in matrix tablets containing diltiazem or metoprolol/λ-carrageenan complexes.
    Bettini R; Bonferoni MC; Colombo P; Zanelotti L; Caramella C
    Biomed Res Int; 2014; 2014():671532. PubMed ID: 25045689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of pH and ionic strength of dissolution media on in-vitro release of two model drugs of different solubilities from HPMC matrices.
    Asare-Addo K; Conway BR; Larhrib H; Levina M; Rajabi-Siahboomi AR; Tetteh J; Boateng J; Nokhodchi A
    Colloids Surf B Biointerfaces; 2013 Nov; 111():384-91. PubMed ID: 23850747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of complex solubility on formulations based on lambda carrageenan and basic drugs.
    Aguzzi C; Bonferoni MC; Fortich MR; Rossi S; Ferrari F; Caramella C
    AAPS PharmSciTech; 2002; 3(3):E27. PubMed ID: 12916942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-organic electrolyte complexes as controlled release systems.
    Vadlapatla R; Fifer EK; Kim CJ; Alexander KS
    Drug Dev Ind Pharm; 2009 Jan; 35(1):1-11. PubMed ID: 18991061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of solvent on retarding the release of diltiazem HCl from Polyox-based liquisolid tablets.
    Kaialy W; Bello H; Asare-Addo K; Nokhodchi A
    J Pharm Pharmacol; 2016 Nov; 68(11):1396-1402. PubMed ID: 27714817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained release characteristics of tablets prepared with mixed matrix of sodium carrageenan and chitosan: effect of polymer weight ratio, dissolution medium, and drug type.
    Bani-Jaber A; Al-Ghazawi M
    Drug Dev Ind Pharm; 2005 Mar; 31(3):241-7. PubMed ID: 15830719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elucidation of release characteristics of highly soluble drug trimetazidine hydrochloride from chitosan-carrageenan matrix tablets.
    Li L; Wang L; Shao Y; Tian Y; Li C; Li Y; Mao S
    J Pharm Sci; 2013 Aug; 102(8):2644-54. PubMed ID: 23754467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a matrix tablet prepared with polyacrylamide-g-sodium alginate co-polymers and their partially hydrolyzed co-polymers for sustained release of diltiazem hydrochloride.
    Mandal S; Ray R; Basu SK; Sa B
    J Biomater Sci Polym Ed; 2010; 21(13):1799-814. PubMed ID: 20557689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and in vitro dissolution profile of dual polymer (Eudragit RS100 and RL100) microparticles of diltiazem hydrochloride.
    Das SK; Das NG
    J Microencapsul; 1998; 15(4):445-52. PubMed ID: 9651866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design of floating bilayer tablets of diltiazem hydrochloride and lovastatin.
    Kulkarni AS; Bhatia MS
    PDA J Pharm Sci Technol; 2008; 62(5):344-52. PubMed ID: 19055230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Divisability of diltiazem matrix sustained-release tablets.
    Costa P; Sousa Lobo JM
    Pharm Dev Technol; 2001 Aug; 6(3):343-51. PubMed ID: 11485176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An investigation into the stabilization of diltiazem HCl release from matrices made from aged polyox powders.
    Shojaee S; Asare-Addo K; Kaialy W; Nokhodchi A; Cumming I
    AAPS PharmSciTech; 2013 Sep; 14(3):1190-8. PubMed ID: 23900884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the employment of lambda carrageenan in a matrix system. III. Optimization of a lambda carrageenan-HPMC hydrophilic matrix.
    Bonferoni MC; Rossi S; Ferrari F; Bertoni M; Bolhuis GK; Caramella C
    J Control Release; 1998 Feb; 51(2-3):231-9. PubMed ID: 9685921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of dissolution medium on the release of diltiazem hydrochloride from carbomeric matrices].
    Sedláková M; Rabisková M; Svajdlenka E
    Ceska Slov Farm; 2006 Mar; 55(2):65-71. PubMed ID: 16570583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug release from complexes with a series of poly(carboxyalkyl methacrylates), a new class of weak polyelectrolytes.
    Cornejo-Bravo JM; Flores-Guillen ME; Lugo-Medina E; Licea-Claverie A
    Int J Pharm; 2005 Nov; 305(1-2):52-60. PubMed ID: 16226001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled-release tablets from carrageenans: effect of formulation, storage and dissolution factors.
    Gupta VK; Hariharan M; Wheatley TA; Price JC
    Eur J Pharm Biopharm; 2001 May; 51(3):241-8. PubMed ID: 11343889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformational energetics of interpolyelectrolyte complexation between ι-carrageenan and poly(methylaminophosphazene) measured by high-sensitivity differential scanning calorimetry.
    Grinberg VY; Burova TV; Grinberg NV; Dubovik AS; Tur DR; Usov AI; Papkov VS; Khokhlov AR
    Langmuir; 2011 Jun; 27(12):7714-21. PubMed ID: 21612233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.